Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Feb;35(2):260–265. doi: 10.1136/gut.35.2.260

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

P Michieletti 1, I R Wanless 1, A Katz 1, P J Scheuer 1, S J Yeaman 1, M F Bassendine 1, J M Palmer 1, E J Heathcote 1
PMCID: PMC1374505  PMID: 8307480

Abstract

This study reports on a group of 20 patients with an initial diagnosis of primary biliary cirrhosis (PBC) whose serum tested negative for antimitochondrial antibodies by immunofluorescence. All had a clinical history compatible with primary biliary cirrhosis, and results of biochemical, histological, and radiological investigations were consistent with this diagnosis despite the absence of antimitochondrial antibodies by immunofluorescence. For comparison, these patients were matched for sex and serum bilirubin with 20 antimitochondrial antibody positive (> 1:160) and histologically confirmed primary biliary cirrhosis patients who served as controls. Serum samples from both groups were retested blindly for antimitochondrial antibodies using immunoblotting and for antibodies to the major M2 mitochondrial autoantigens by enzyme linked immunosorbent assay (ELISA). Three antimitochondrial antibody immunofluorescence negative patients had antimitochondrial antibodies by immunoblotting and ELISA; the remaining 17 patients were confirmed negative by all methods. The antimitochondrial antibody immunofluorescence positive controls were verified by immunoblotting or ELISA, or both. All 17 patients negative for antimitochondrial antibodies had antinuclear antibodies, often in high titres, compared with 3/17 of the antimitochondrial antibody positive controls (p = 0.0001). Additionally, the antimitochondrial antibody negative group also had significantly higher smooth muscle antibody titres (p = 0.03) and lower serum IgM (p = 0.01) and aspartate aminotransferase (p = 0.03) activities than the antimitochondrial antibody positive controls. Analysis of clinical findings, histological tests, serum bilirubin, alkaline phosphatase, alanine aminotransferase, and IgG, disclosed no significant differences between the two groups. This paper describes a group of patients with the clinical and histological features of PBC but who do not fulfil the usual criteria necessary to make this diagnosis. Because they also have very high titres of antinuclear antibodies, smooth muscle antibodies, and comparatively low IgM and aspartate aminotransferase activities, we believe they are distinct from PBC and have a syndrome of autoimmune cholangitis.

Full text

PDF
262

Images in this article

262Figure 1
on p.262
262Figure 2
on p.262
263Figure 3
on p.263
263Figure 4
on p.263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassendine M. F., Yeaman S. J. Primary biliary cirrhosis: nature of autoantigens. Springer Semin Immunopathol. 1990;12(1):73–83. doi: 10.1007/BF00192684. [DOI] [PubMed] [Google Scholar]
  2. Bernstein R. M., Neuberger J. M., Bunn C. C., Callender M. E., Hughes G. R., Williams R. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol. 1984 Mar;55(3):553–560. [PMC free article] [PubMed] [Google Scholar]
  3. Beutner E. H., Sepulveda M. R., Barnett E. V. Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors. Bull World Health Organ. 1968;39(4):587–606. [PMC free article] [PubMed] [Google Scholar]
  4. Brunner G., Klinge O. Ein der chronisch-destruierenden nicht-eitrigen Cholangitis ähnliches Krankheitsbild mit antinukleären Antikörpern (Immuncholangitis). Dtsch Med Wochenschr. 1987 Sep 18;112(38):1454–1458. doi: 10.1055/s-2008-1068269. [DOI] [PubMed] [Google Scholar]
  5. Carrougher J. G., Shaffer R. T., Canales L. I., Goodman Z. D. A 33-year-old woman with an autoimmune syndrome. Semin Liver Dis. 1991 Aug;11(3):256–262. doi: 10.1055/s-2008-1040444. [DOI] [PubMed] [Google Scholar]
  6. Faa G., Van Eyken P., Demelia L., Vallebona E., Costa V., Desmet V. J. Idiopathic adulthood ductopenia presenting with chronic recurrent cholestasis. A case report. J Hepatol. 1991 Jan;12(1):14–20. doi: 10.1016/0168-8278(91)90902-n. [DOI] [PubMed] [Google Scholar]
  7. Fussey S. P., Guest J. R., James O. F., Bassendine M. F., Yeaman S. J. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8654–8658. doi: 10.1073/pnas.85.22.8654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fussey S. P., Lindsay J. G., Fuller C., Perham R. N., Dale S., James O. F., Bassendine M. F., Yeaman S. J. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Hepatology. 1991 Mar;13(3):467–474. [PubMed] [Google Scholar]
  9. Galambos J. T., Brooks W. S., Jr Atypical biliary cirrhosis--or sclerosing cholangitis. J Clin Gastroenterol. 1980 Mar;2(1):43–52. doi: 10.1097/00004836-198003000-00008. [DOI] [PubMed] [Google Scholar]
  10. Goudie R. B., Macsween R. N., Goldberg D. M. Serological and histological diagnosis of primary biliary cirrhosis. J Clin Pathol. 1966 Nov;19(6):527–538. doi: 10.1136/jcp.19.6.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Heseltine L., Turner I. B., Fussey S. P., Kelly P. J., James O. F., Yeaman S. J., Bassendine M. F. Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology. 1990 Dec;99(6):1786–1792. doi: 10.1016/0016-5085(90)90488-m. [DOI] [PubMed] [Google Scholar]
  12. Klatskin G., Kantor F. S. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med. 1972 Oct;77(4):533–541. doi: 10.7326/0003-4819-77-4-533. [DOI] [PubMed] [Google Scholar]
  13. Klöppel G., Seifert G., Lindner H., Dammermann R., Sack H. J., Berg P. A. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch A Pathol Anat Histol. 1977 Mar 11;373(2):143–160. doi: 10.1007/BF00432159. [DOI] [PubMed] [Google Scholar]
  14. Laemmli U. K., Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973 Nov 15;80(4):575–599. doi: 10.1016/0022-2836(73)90198-8. [DOI] [PubMed] [Google Scholar]
  15. Lassoued K., Brenard R., Degos F., Courvalin J. C., Andre C., Danon F., Brouet J. C., Zine-el-Abidine Y., Degott C., Zafrani S. Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology. 1990 Jul;99(1):181–186. doi: 10.1016/0016-5085(90)91246-3. [DOI] [PubMed] [Google Scholar]
  16. Leung P. S., Iwayama T., Prindiville T., Chuang D. T., Ansari A. A., Wynn R. M., Dickson R., Coppel R., Gershwin M. E. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. Hepatology. 1992 Mar;15(3):367–372. doi: 10.1002/hep.1840150302. [DOI] [PubMed] [Google Scholar]
  17. Lozano F., Parés A., Borche L., Plana M., Gallart T., Rodés J., Vives J. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology. 1988 Jul-Aug;8(4):930–938. doi: 10.1002/hep.1840080438. [DOI] [PubMed] [Google Scholar]
  18. Ludwig J., Dickson E. R., McDonald G. S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978 Aug 22;379(2):103–112. doi: 10.1007/BF00432479. [DOI] [PubMed] [Google Scholar]
  19. Ludwig J., Wiesner R. H., LaRusso N. F. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol. 1988 Oct;7(2):193–199. doi: 10.1016/s0168-8278(88)80482-3. [DOI] [PubMed] [Google Scholar]
  20. Munoz L. E., Thomas H. C., Scheuer P. J., Doniach D., Sherlock S. Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut. 1981 Feb;22(2):136–140. doi: 10.1136/gut.22.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Okuno T., Seto Y., Okanoue T., Takino T. Chronic active hepatitis with histological features of primary biliary cirrhosis. Dig Dis Sci. 1987 Jul;32(7):775–779. doi: 10.1007/BF01296147. [DOI] [PubMed] [Google Scholar]
  22. Powell F., Schroeter A. L., Dickson E. R. Antinuclear antibodies in primary biliary cirrhosis. Lancet. 1984 Feb 4;1(8371):288–289. doi: 10.1016/s0140-6736(84)90164-8. [DOI] [PubMed] [Google Scholar]
  23. Stanley C. J., Perham R. N. Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J. 1980 Oct 1;191(1):147–154. doi: 10.1042/bj1910147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Szostecki C., Guldner H. H., Netter H. J., Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol. 1990 Dec 15;145(12):4338–4347. [PubMed] [Google Scholar]
  25. Van de Water J., Ansari A. A., Surh C. D., Coppel R., Roche T., Bonkovsky H., Kaplan M., Gershwin M. E. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol. 1991 Jan 1;146(1):89–94. [PubMed] [Google Scholar]
  26. Van de Water J., Cooper A., Surh C. D., Coppel R., Danner D., Ansari A., Dickson R., Gershwin M. E. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med. 1989 May 25;320(21):1377–1380. doi: 10.1056/NEJM198905253202104. [DOI] [PubMed] [Google Scholar]
  27. Van de Water J., Fregeau D., Davis P., Ansari A., Danner D., Leung P., Coppel R., Gershwin M. E. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol. 1988 Oct 1;141(7):2321–2324. [PubMed] [Google Scholar]
  28. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]
  29. Ward A. M., Ellis G., Goldberg D. M. Serum immunoglobulin concentrations and autoantibody titers in diseases of the liver and biliary tree. Am J Clin Pathol. 1978 Sep;70(3):352–358. doi: 10.1093/ajcp/70.3.352. [DOI] [PubMed] [Google Scholar]
  30. Yeaman S. J., Fussey S. P., Danner D. J., James O. F., Mutimer D. J., Bassendine M. F. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet. 1988 May 14;1(8594):1067–1070. doi: 10.1016/s0140-6736(88)91894-6. [DOI] [PubMed] [Google Scholar]
  31. Zafrani E. S., Metreau J. M., Douvin C., Larrey D., Massari R., Reynes M., Doffoel M., Benhamou J. P., Dhumeaux D. Idiopathic biliary ductopenia in adults: a report of five cases. Gastroenterology. 1990 Dec;99(6):1823–1828. doi: 10.1016/0016-5085(90)90494-l. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES